Brenton Harold Zettl, President & Chief Executive Officer at CanniMed Therapeutics Inc, holds 34.58M shares in ZYUS Life Sciences (Ticker: TSE:ZYUS), holds 2.13M shares in CanniMed Therapeutics Inc (Ticker: CMMDF). Most recently, Brenton Harold Zettl Bought ― shares of ZYUS Life Sciences on Feb 01, 2024 for an estimated value of 169.28K.
What is the percentage of profitable transactions made by Brenton Harold Zettl?
The percentage of profitable transactions made by Brenton Harold Zettl is 75%.
What is the average return per transaction made by Brenton Harold Zettl?
The average return per transaction made by Brenton Harold Zettl is 258.00%.
What stocks does Brenton Harold Zettl hold?
Brenton Harold Zettl holds: CMMDF, TSE:ZYUS stocks.
What was Brenton Harold Zettl’s latest transaction?
Brenton Harold Zettl latest transaction was an Informative Buy of C$169.28K.
What was Brenton Harold Zettl's most profitable transaction?
Brenton Harold Zettl’s most profitable transaction was an Informative Buy of CMMDF stock on June 19, 2017. The return on the trade was 362.70%.
What is Brenton Harold Zettl's role in CanniMed Therapeutics Inc?
Brenton Harold Zettl's role in CanniMed Therapeutics Inc is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.